Clinical proton MR spectroscopy in central nervous system disorders.
暂无分享,去创建一个
Jens Frahm | Anke Henning | Peter R Luijten | Dennis W J Klomp | Eva-Maria Ratai | Rolf Gruetter | Stephan Gruber | Andrew C Peet | Hoby P Hetherington | Jullie W Pan | Robert Bartha | Peter B Barker | Andrew A Maudsley | Arend Heerschap | Daniel B Vigneron | Alberto Bizzi | Chris Boesch | Jeffry R Alger | Ulrike Dydak | Martin O Leach | Stefan Posse | Carolyn E Mountford | Brian J Soher | Ivan Tkáč | Alp Dinçer | Brian D Ross | Roland Kreis | Franklyn A Howe | Harish Poptani | Uzay E Emir | Patrick J Bolan | Kevin M Brindle | Cristina Cudalbu | Ralph E Hurd | Risto A Kauppinen | Dieter J Meyerhoff | Sarah J Nelson | R. Kauppinen | T. Scheenen | R. Gonzalez | R. Kreis | C. Boesch | S. Nelson | D. Vigneron | R. Gruetter | I. Tkáč | A. Bizzi | S. Posse | J. Frahm | R. Bartha | P. Hüppi | A. Henning | B. Ross | P. Barker | U. Dydak | J. Alger | F. Howe | A. Maudsley | A. Heerschap | P. Pouwels | Rakesh K. Gupta | A. Dinçer | M. Pamir | K. Brindle | C. Mountford | M. Leach | D. Meyerhoff | M. Marjańska | P. Luijten | D. Klomp | C. Cudalbu | B. Soher | H. Hetherington | E. Ratai | S. Gruber | P. Bolan | Harish Poptani | A. Peet | R. Hurd | U. Emir | I. Smith | A. Lin | G. Oz | C. Schuster | Rakesh K Gupta | Petra J W Pouwels | Petra S Hüppi | Christian Schuster | Kantarci Kantarci | M. Kruiskamp | Gülin Oz | Ramón Gilberto González | Kantarci Kantarci | Marijn J Kruiskamp | Alexander P Lin | Malgorzata Marjańska | M Necmettin Pamir | Tom W Scheenen | Ian C P Smith | R. González
[1] D. Arnold,et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis , 2002, Journal of Neurology.
[2] Paul A. Bottomley,et al. 4480228 Selective volume method for performing localized NMR spectroscopy , 1985 .
[3] G. Fein,et al. Ethanol in human brain by magnetic resonance spectroscopy: correlation with blood and breath levels, relaxation, and magnetization transfer. , 2000, Alcoholism, clinical and experimental research.
[4] F. Gilles,et al. Elevated citrate in pediatric astrocytomas with malignant progression. , 2011, Neuro-oncology.
[5] R. L. Somorjai,et al. Creating robust, reliable, clinically relevant classifiers from spectroscopic data , 2009, Biophysical Reviews.
[6] N. Jetté,et al. Epilepsy surgery utilization: who, when, where, and why? , 2012, Current opinion in neurology.
[7] R. Bartha,et al. Reduced hippocampal glutamate in Alzheimer disease , 2011, Neurobiology of Aging.
[8] Margarida Julià-Sapé,et al. Prospective diagnostic performance evaluation of single‐voxel 1H MRS for typing and grading of brain tumours , 2012, NMR in biomedicine.
[9] H. Moser,et al. Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy , 2002, Neurology.
[10] Glyn Johnson,et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.
[11] H. R. Griffith,et al. Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment. , 2009, International review of neurobiology.
[12] J. Shih,et al. Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma , 2011, Journal of Neuro-Oncology.
[13] G. Reynés,et al. Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas , 2010, Journal of Clinical Neuroscience.
[14] B. Manley,et al. Intracerebral blood and MRS in neonatal nonketotic hyperglycinemia. , 2010, Pediatric neurology.
[15] G. Barker,et al. Detection of myelin breakdown products by proton magnetic resonance spectroscopy , 1993, The Lancet.
[16] R. Bartha,et al. High field 1H MRS of the hippocampus after donepezil treatment in Alzheimer disease , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[17] H. Poptani,et al. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. , 1995, AJNR. American journal of neuroradiology.
[18] R. Maciunas,et al. Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme. , 2012, International journal of radiation oncology, biology, physics.
[19] D. Gadian,et al. Magnetic resonance spectroscopy in temporal lobe epilepsy , 1994, Neurology.
[20] N. Marlow,et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. , 2009, The New England journal of medicine.
[21] Ewald Moser,et al. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas , 2004, NeuroImage.
[22] V. Calhoun,et al. Test‐retest reliability and reproducibility of short‐echo‐time spectroscopic imaging of human brain at 3T , 2011, Magnetic resonance in medicine.
[23] J. Frahm,et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.
[24] P. Barker,et al. Can Proton MR Spectroscopic and Perfusion Imaging Differentiate Between Neoplastic and Nonneoplastic Brain Lesions in Adults? , 2008, American Journal of Neuroradiology.
[25] S. Provencher. Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.
[26] K. Uğurbil,et al. In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T , 2009, Magnetic resonance in medicine.
[27] Joseph R. Smith,et al. Temporal pole proton preoperative magnetic resonance spectroscopy in patients undergoing surgery for mesial temporal sclerosis. , 2012, Neurosurgical focus.
[28] I. Marshall,et al. Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. , 1998, Stroke.
[29] A. Algra,et al. Magnetic Resonance Techniques for the Identification of Patients With Symptomatic Carotid Artery Occlusion at High Risk of Cerebral Ischemic Events , 2000, Stroke.
[30] Theodoros N. Arvanitis,et al. Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours , 2013, European journal of cancer.
[31] R. Kreis. Issues of spectral quality in clinical 1H‐magnetic resonance spectroscopy and a gallery of artifacts , 2004, NMR in biomedicine.
[32] Propylene Glycol Is Essential in the LCModel Basis Set for Pediatric 1H-MRS , 2005, Journal of computer assisted tomography.
[33] J. Frahm,et al. Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy , 1989, Magnetic resonance in medicine.
[34] Xin Yu,et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. , 2003, The American journal of psychiatry.
[35] R. Reilmann,et al. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease , 2010, Neurology.
[36] O. Gonen,et al. Whole-Brain N-Acetylaspartate as a Surrogate Marker of Neuronal Damage in Diffuse Neurologic Disorders , 2007, American Journal of Neuroradiology.
[37] Stephanie C. Licata,et al. Annals of the New York Academy of Sciences Neurochemistry of Drug Action Insights from Proton Magnetic Resonance Spectroscopic Imaging and Their Relevance to Addiction , 2022 .
[38] L. Rorke,et al. In vivo pyruvate detected by MR spectroscopy in neonatal pyruvate dehydrogenase deficiency. , 2003, AJNR. American journal of neuroradiology.
[39] R. Gruetter,et al. Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients , 2005, Neurology.
[40] K. Uğurbil,et al. Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength. , 1998, Journal of magnetic resonance.
[41] A. Bizzi,et al. Classification of Childhood White Matter Disorders Using Proton MR Spectroscopic Imaging , 2008, American Journal of Neuroradiology.
[42] A. Pfefferbaum,et al. Reproducibility study of whole‐brain 1H spectroscopic imaging with automated quantification , 2008, Magnetic resonance in medicine.
[43] Jens Frahm,et al. Creatine replacement therapy in guanidineoacetate methyltransferase deficiency, a novel inborn error of metabolism , 1996, The Lancet.
[44] A. Schulze. Creatine deficiency syndromes , 2003, Molecular and Cellular Biochemistry.
[45] B. Siesjö,et al. Brain energy metabolism , 1978 .
[46] J. Neale,et al. Immunohistochemical localization of N-acetylaspartate in rat brain. , 1991, Neuroreport.
[47] H P Hetherington,et al. J‐refocused coherence transfer spectroscopic imaging at 7 T in human brain , 2010, Magnetic resonance in medicine.
[48] H. Mefford,et al. Creatine Deficiency Syndromes -- GeneReviews(®) , 2016 .
[49] D P Auer,et al. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain , 1995, NMR in biomedicine.
[50] V. Govindaraju,et al. Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.
[51] T. W. May,et al. The role of 1H magnetic resonance spectroscopy in pre-operative evaluation for epilepsy surgery A meta-analysis , 2006, Epilepsy Research.
[52] R. Gonzalez,et al. Clinical MRI of acute ischemic stroke , 2012, Journal of magnetic resonance imaging : JMRI.
[53] C. Jack,et al. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. , 2008, Radiology.
[54] S. Renowden,et al. Magnetic Resonance of Myelination and Myelin Disorders , 2006, Journal of Neurology.
[55] P. Kwan,et al. Early identification of refractory epilepsy. , 2000, The New England journal of medicine.
[56] Ann Saada,et al. Leukoencephalopathy with accumulated succinate is indicative of SDHAF1 related complex II deficiency , 2012, Orphanet Journal of Rare Diseases.
[57] Sanjeev Chawla,et al. Proton Magnetic Resonance Spectroscopy in Differentiating Glioblastomas From Primary Cerebral Lymphomas and Brain Metastases , 2010, Journal of computer assisted tomography.
[58] E. Beghi,et al. Early versus late remission in a cohort of patients with newly diagnosed epilepsy , 2010, Epilepsia.
[59] J. Finsterbusch,et al. Quantitative proton magnetic resonance spectroscopy of children with adrenoleukodystrophy before and after hematopoietic stem cell transplantation. , 2003, Neuropediatrics.
[60] Hitten P. Zaveri,et al. Neurometabolism in human epilepsy , 2008, Epilepsia.
[61] V. L. Doyle,et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy , 2003, Magnetic resonance in medicine.
[62] Gülin Öz,et al. Short‐echo, single‐shot, full‐intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: Validation in the cerebellum and brainstem , 2011, Magnetic resonance in medicine.
[63] R. Kreis,et al. Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy. , 1996, The Journal of clinical investigation.
[64] P. Aubourg,et al. Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy. , 2008, Current opinion in molecular therapeutics.
[65] M. Weiner,et al. Temporal lobe epilepsy: qualitative reading of 1H MR spectroscopic images for presurgical evaluation. , 2001, Radiology.
[66] Pieter Wesseling,et al. Accurate classification of childhood brain tumours by in vivo ¹H MRS - a multi-centre study. , 2013, European journal of cancer.
[67] Rolf Gruetter,et al. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T , 2009, Magnetic resonance in medicine.
[68] G. Barker,et al. Proton MR spectroscopy of metabolite concentrations in temporal lobe epilepsy and effect of temporal lobe resection , 2009, Epilepsy Research.
[69] M. C. Han,et al. In vivo single-voxel proton MR spectroscopy in intracranial cystic masses. , 1998, AJNR. American journal of neuroradiology.
[70] P M Matthews,et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies , 2007, Neurology.
[71] E. Sullivan,et al. Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease , 2000, The Lancet.
[72] T. Richards. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. , 1991, AJR. American journal of roentgenology.
[73] Uzay E. Emir,et al. Elevated Pontine and Putamenal GABA Levels in Mild-Moderate Parkinson Disease Detected by 7 Tesla Proton MRS , 2012, PloS one.
[74] P Boesiger,et al. Pitfalls in lactate measurements at 3T. , 2006, AJNR. American journal of neuroradiology.
[75] Aaron Carass,et al. Brain metabolite alterations and cognitive dysfunction in early Huntington's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[76] P. Pouwels,et al. Magnetic Resonance Spectroscopy: Basic Principles and Application in White Matter Disorders , 2005 .
[77] J. Frahm,et al. Localized Proton Magnetic Resonance Spectroscopy of Brain Disorders in Childhood , 1997 .
[78] J. Frahm,et al. Quantitative Proton Magnetic Resonance Spectroscopy of Cerebral Metabolic Disturbances in Patients with MELAS , 1999, Neuropediatrics.
[79] E G Tangalos,et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.
[80] A. Hansen,et al. Journal of Cerebral Blood Flow and Metabolism Changes in N-acetyl-aspartate Content during Focal and Global Brain Ischemia of the Rat , 2022 .
[81] A. Hart,et al. Childhood white matter disorders: quantitative MR imaging and spectroscopy. , 2006, Radiology.
[82] Sabine Van Huffel,et al. Multiproject–multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.
[83] E. Chang,et al. Rates and predictors of long-term seizure freedom after frontal lobe epilepsy surgery: a systematic review and meta-analysis. , 2012, Journal of neurosurgery.
[84] P. Boesiger,et al. 1H-MR Spectroscopy in the Human Spinal Cord , 2013, American Journal of Neuroradiology.
[85] M Noble,et al. Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In Vitro , 1992, Journal of neurochemistry.
[86] T. Scheenen,et al. Quantitative short echo time 1H MRSI of the peripheral edematous region of human brain tumors in the differentiation between glioblastoma, metastasis, and meningioma , 2012, Journal of magnetic resonance imaging : JMRI.
[87] F. Eichler,et al. Metachromatic Leukodystrophy: A Scoring System for Brain MR Imaging Observations , 2009, American Journal of Neuroradiology.
[88] D. Gadian,et al. Localized 1H NMR spectroscopy in Canavan's Disease: A report of two cases , 1991, Magnetic resonance in medicine.
[89] P. Barber,et al. Combined 1H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome , 2000, Neurology.
[90] Olivier Scheidegger,et al. Optimized quantitative magnetic resonance spectroscopy for clinical routine , 2013, Magnetic resonance in medicine.
[91] Jens Frahm,et al. Regional Age Dependence of Human Brain Metabolites from Infancy to Adulthood as Detected by Quantitative Localized Proton MRS , 1999, Pediatric Research.
[92] H. Tallan. Studies on the distribution of N-acetyl-L-aspartic acid in brain. , 1957, The Journal of biological chemistry.
[93] Jullie W Pan,et al. Selective homonuclear polarization transfer for spectroscopic imaging of GABA at 7T , 2013, Magnetic resonance in medicine.
[94] Theodoros N. Arvanitis,et al. Non‐invasive detection of glycine as a biomarker of malignancy in childhood brain tumours using in‐vivo 1H MRS at 1.5 Tesla confirmed by ex‐vivo high‐resolution magic‐angle spinning NMR , 2010, NMR in biomedicine.
[95] David G. Gadian,et al. Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.
[96] Der,et al. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. , 1990, Radiology.
[97] Peter M. G. Munro,et al. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. , 1996, Neuroreport.
[98] Elias R Melhem,et al. Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience. , 2007, Radiology.
[99] J. Frahm,et al. Quantitative Proton Magnetic Resonance Spectroscopy of Childhood Adrenoleukodystrophy , 1998, Neuropediatrics.
[100] Jens Frahm,et al. Localized proton spectroscopy using stimulated echoes. , 1987 .
[101] B D Ross,et al. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. , 1993, Radiology.
[102] Jimmy D Bell,et al. Persistent Increases in Cerebral Lactate Concentration after Birth Asphyxia , 1998, Pediatric Research.
[103] R. Somorjai,et al. Deriving biomedical diagnostics from NMR spectroscopic data , 2011, Biophysical Reviews.
[104] O Ganslandt,et al. Short TE single‐voxel 1H‐MR spectroscopy of hippocampal structures in healthy adults at 1.5 Tesla—how reproducible are the results? , 2005, NMR in biomedicine.
[105] D. Gadian,et al. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy , 1996, Annals of neurology.
[106] J. Langlois,et al. The Incidence of Traumatic Brain Injury Among Children in the United States: Differences by Race , 2005, The Journal of head trauma rehabilitation.
[107] Mitchel S Berger,et al. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. , 2007, Journal of neurosurgery.
[108] B. Ross,et al. Impact of evidence‐based medicine on magnetic resonance spectroscopy , 2006, NMR in biomedicine.
[109] C. Jack,et al. MRS in presymptomatic MAPT mutation carriers , 2010, Neurology.
[110] D. Saunders,et al. MR spectroscopy in stroke. , 2000, British medical bulletin.
[111] K. Bushara,et al. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status , 2010, Movement disorders : official journal of the Movement Disorder Society.
[112] A. Bizzi,et al. X‐linked creatine deficiency syndrome: A novel mutation in creatine transporter gene SLC6A8 , 2002, Annals of neurology.
[113] B. Miller. A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.
[114] J. Frahm,et al. Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders. , 1992, Journal of computer assisted tomography.
[115] W. Heindel,et al. Noninvasive detection of increased glycine content by proton MR spectroscopy in the brains of two infants with nonketotic hyperglycinemia. , 1993, AJNR. American journal of neuroradiology.
[116] M N Rossor,et al. MRS shows abnormalities before symptoms in familial Alzheimer disease , 2006, Neurology.
[117] Andrew C Peet,et al. MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation , 2011, Orphanet journal of rare diseases.
[118] Kenneth R. Maravilla,et al. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging , 2010, Neuroradiology.
[119] J. Barkovich,et al. Developmental progress and creatine restoration upon long-term creatine supplementation of a patient with arginine:glycine amidinotransferase deficiency. , 2012, Molecular genetics and metabolism.
[120] P. Courtoy,et al. Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. , 2009, The Biochemical journal.
[121] Jens Frahm,et al. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo , 1993, Journal of Neurology.
[122] H. B. Verheul,et al. Changes in metabolites and tissue water status after focal ischemia in cat brain assessed with localized proton MR spectroscopy , 1994, Magnetic resonance in medicine.
[123] B. Mueller,et al. Signal‐to‐noise ratio and spectral linewidth improvements between 1.5 and 7 Tesla in proton echo‐planar spectroscopic imaging , 2006, Magnetic resonance in medicine.
[124] Arend Heerschap,et al. Short echo time 1H MRSI of the human brain at 3T with adiabatic slice‐selective refocusing pulses; reproducibility and variance in a dual center setting , 2010, Journal of magnetic resonance imaging : JMRI.
[125] R. Gupta,et al. Higher succinate than acetate levels differentiate cerebral degenerating cysticerci from anaerobic abscesses on in-vivo proton MR spectroscopy , 2004, Neuroradiology.
[126] M. Leach,et al. Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value? , 2003, The British journal of radiology.
[127] Dennis G. Fryback,et al. The Efficacy of Diagnostic Imaging , 1991, Medical decision making : an international journal of the Society for Medical Decision Making.
[128] J R Griffiths,et al. Linear discriminant analysis of brain tumour 1H MR spectra: a comparison of classification using whole spectra versus metabolite quantification , 2007, NMR in biomedicine.
[129] P M Matthews,et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.
[130] R. Ramsay,et al. Application of volumetric MR spectroscopic imaging for localization of neocortical epilepsy , 2010, Epilepsy Research.
[131] P. Hüppi,et al. Chapter 13 – Magnetic Resonance Imaging's Role in the Care of the Infant at Risk for Brain Injury , 2008 .
[132] Mike P. Wattjes,et al. Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter , 2013, European Radiology.
[133] Michael Garwood,et al. Localized 1H NMR spectroscopy in different regions of human brain in vivo at 7 T: T2 relaxation times and concentrations of cerebral metabolites , 2012, NMR in biomedicine.
[134] J. Frahm,et al. Multiple sclerosis in childhood: Report of 15 cases , 1991, Brain and Development.
[135] T. Strom,et al. SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy , 2009, Nature Genetics.
[136] A. Dinçer,et al. First intraoperative, shared-resource, ultrahigh-field 3-Tesla magnetic resonance imaging system and its application in low-grade glioma resection. , 2010, Journal of neurosurgery.
[137] Stephen Ashwal,et al. Magnetic Resonance Spectroscopy Predicts Outcomes for Children With Nonaccidental Trauma , 2010, Pediatrics.
[138] Clifford R. Jack,et al. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease , 2007, Neurobiology of Aging.
[139] M. Leach,et al. Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy , 2004, British Journal of Cancer.
[140] Dennis W J Klomp,et al. Short echo time 1H‐MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses , 2008, Magnetic resonance in medicine.
[141] A. Blamire,et al. Spectroscopic imaging of stroke in humans , 1992, Neurology.
[142] L. Hanson,et al. Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy , 2010, Neurology.
[143] J. Slotboom,et al. Quantitative 1H‐magnetic resonance spectroscopy of human brain: Influence of composition and parameterization of the basis set in linear combination model‐fitting , 2002, Magnetic resonance in medicine.
[144] Christian Confavreux,et al. Correlation of Diffusion and Metabolic Alterations in Different Clinical Forms of Multiple Sclerosis , 2012, PloS one.
[145] T. Crawford,et al. Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. , 2001, AJNR. American journal of neuroradiology.
[146] D. Knol,et al. Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect , 2011, Journal of Inherited Metabolic Disease.
[147] B D Ross,et al. In vivo MR spectroscopy of human dementia. , 1998, Neuroimaging clinics of North America.
[148] V. Calhoun,et al. Test-Retest Reliability and Reproducibility of Short-Echo-Time Spectroscopic Imaging of Human Brain at 3 T , 2011 .
[149] K. Bushara,et al. Distinct Neurochemical Profiles of Spinocerebellar Ataxias 1, 2, 6, and Cerebellar Multiple System Atrophy , 2011, The Cerebellum.
[150] Arend Heerschap,et al. Towards 1H-MRSI of the human brain at 7T with slice-selective adiabatic refocusing pulses , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.
[151] J. Frahm,et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.
[152] P. Bottomley. The trouble with spectroscopy papers , 1992, Journal of magnetic resonance imaging : JMRI.
[153] Jeroen van der Grond,et al. Cerebral Lactate and N-Acetyl-Aspartate/Choline Ratios in Asphyxiated Full-Term Neonates Demonstrated In Vivo Using Proton Magnetic Resonance Spectroscopy , 1994, Pediatric Research.
[154] J Hennig,et al. Absence of N‐acetylaspartate in the human brain: Impact on neurospectroscopy? , 2001, Annals of neurology.
[155] François Lazeyras,et al. Magnetic Resonance in Preterm and Term Newborns: 1H-Spectroscopy in Developing Human Brain , 1991, Pediatric Research.
[156] F. Gilles,et al. Untreated pediatric primitive neuroectodermal tumor in vivo: quantitation of taurine with MR spectroscopy. , 2005, Radiology.
[157] E Moser,et al. Proton T 1 and T 2 relaxation times of human brain metabolites at 3 Tesla , 2001, NMR in biomedicine.
[158] H. Lanfermann,et al. Long‐term neuroimaging follow‐up on an asymptomatic juvenile metachromatic leukodystrophy patient after hematopoietic stem cell transplantation: Evidence of myelin recovery and ongoing brain maturation , 2012, American journal of medical genetics. Part A.
[159] C. Hendriksz,et al. Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome) , 2010, Journal of Inherited Metabolic Disease.
[160] R. Bartha,et al. Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[161] D. Haynor,et al. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects , 2012, Journal of magnetic resonance imaging : JMRI.
[162] P M Matthews,et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. , 2001, Archives of neurology.
[163] G. Sutherland,et al. High‐Resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms , 1992, Magnetic resonance in medicine.
[164] Inas S. Khayal,et al. Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM , 2009, Journal of Neuro-Oncology.
[165] A. W. Simonetti,et al. Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra , 2006, NMR in biomedicine.
[166] D. Gusnard,et al. Regional variation in brain lactate in leigh syndrome by localized 1H magnetic resonance spectroscopy , 1991, Annals of neurology.
[167] Soonmee Cha,et al. Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma , 2009, Journal of Neuro-Oncology.
[168] Oded Gonen,et al. Reproducibility of 3D proton spectroscopy in the human brain , 2002, Magnetic resonance in medicine.
[169] C H Polman,et al. MR spectroscopic evidence for glial increase but not for neuro‐axonal damage in MS normal‐appearing white matter , 2005, Magnetic resonance in medicine.
[170] P. Dechent,et al. Untreated glioblastoma multiforme: increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy. , 2009, Radiology.
[171] Mark Noble,et al. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours , 1995, NMR in biomedicine.